isoxazoles has been researched along with afoxolaner in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 49 (76.56) | 24.3611 |
| 2020's | 15 (23.44) | 2.80 |
| Authors | Studies |
|---|---|
| Chester, TS; Dumont, P; Fourie, JJ; Hunter, JS; Larsen, DL; Young, DR | 1 |
| Blair, J; Chester, TS; Dumont, P; Fourie, JJ; Larsen, DL | 1 |
| Daly, S; Drag, M; Dumont, P; Kunkle, B; Larsen, D | 1 |
| Chester, TS; Drag, M; Kinoshita, G; Kondo, Y; Larsen, D | 1 |
| Otranto, D | 1 |
| Drag, M; Harriman, J; Larsen, D; Saik, J | 1 |
| Benner, EA; Confalone, PN; Cordova, D; Dietrich, RF; Gould, BR; Hartline, EJ; Jones, GS; Kinney, JB; Lahm, GP; Long, JK; McDowell, RG; Rhoades, DF; Schroeder, ME; Shoop, WL; Waddell, ME; Wagerle, T; Xu, M | 1 |
| Chester, TS; Dumont, P; Gale, B; Larsen, DL | 1 |
| Drag, M; Harriman, J; Huang, R; Kvaternick, V; Letendre, L; Soll, M | 1 |
| Larsen, D; McCall, JW; Mitchell, EB; Theodore Chester, S | 1 |
| Chester, TS; Drag, MD; Kunkle, BN; Larsen, DL | 1 |
| Beugnet, F; Erasmus, H; Fourie, J; Halos, L; Labuschagné, M; Larsen, D | 1 |
| Beugnet, F; deVos, C; Fourie, J; Halos, L; Liebenberg, J | 1 |
| Beugnet, F; Chalvet-Monfray, K; Halos, L; Larsen, D; Lebon, W | 1 |
| Beugnet, F; Halos, L; Liebenberg, J | 2 |
| Carithers, D; Chwala, M; Crevoiserat, L; Dryden, MW; Foley, KM; Hawkins, A; Jones, E; McGrady, JC; Patton, PR; Smith, V | 1 |
| Emmerich, IU | 1 |
| Davis, WL; Everett, WR; Hostetler, J; Ohmes, CM; Settje, T | 1 |
| Rumschlag, AJ; Ryan, WG; Snyder, DE; Young, LM | 1 |
| Anderson, A; de Vos, C; Fourie, JJ; Jeannin, P; Larsen, DL; Rehbein, S | 1 |
| Becskei, C; Cuppens, O; Geurden, T; Liebenberg, J; Mahabir, SP; Six, RH | 1 |
| Beugnet, F; de Vos, C; Halos, L; Larsen, D | 1 |
| Crafford, D; Erasmus, H; Fourie, JJ; Jongejan, F; Schunack, B | 1 |
| Beugnet, F; de Vos, C; Fourie, J; Halos, L; Larsen, D; Liebenberg, J | 1 |
| Bennett, T; Canfield, MS; Crevoiserat, L; Dryden, MW; Foley, KM; Green, K; Heaney, K; Kalosy, K; Math, L; McGrady, JC; Royal, C; Smith, A; Smith, V; Sun, F; Tebaldi, C | 1 |
| Bowman, DD; Crafford, D; Dorr, P; Fankhauser, R; Hamel, D; Larsen, DL; Reinemeyer, CR; Ulrich, M; Yoon, S | 1 |
| Beugnet, F; Crafford, D; de Vos, C; Fourie, J; Kok, D; Larsen, D | 1 |
| Beugnet, F; Dumont, P; Halos, L; Jeannin, P; Larsen, D; Lebon, W; Rehbein, S; Tielemans, E; Yoon, S | 1 |
| Kumar, S; Padivitage, N; Rustum, A | 1 |
| Breiltgens, T; Brianti, E; Capári, B; Dantas-Torres, F; Dollhofer, D; Gau, M; Jeannin, P; Joachim, A; Kaulfuß, KH; Kirkova, Z; Kley, K; Knaus, M; Lebon, W; Lechner, J; Mallouk, Y; Mihalca, AD; Mirabito, R; Petkevičius, S; Rapti, D; Rehbein, S; Sedeilhan, M; Shukullari, E; Visser, M | 1 |
| Drag, M; Harriman, J; Larsen, D; Letendre, L; Saik, J; Yoon, S | 1 |
| Kumar, S; Rustum, A; Zhuang, J | 1 |
| Armstrong, R; Burgio, F; Meyer, L | 1 |
| Carithers, D; Crawford, J; de Vos, C; Fourie, J; Lotriet, A | 1 |
| Bruellke, N; Davis, K; Hodge, A; Maeder, S; Packianathan, R | 1 |
| Dumont, P; Larsen, D; Lebon, W; Rehbein, S; Taweethavonsawat, P; Tielemans, E | 1 |
| Altet, L; Ferrer, L; Lam, ATH; Zewe, CM | 1 |
| Beugnet, F; Fourie, J; Halos, L; Larsen, D; Lebon, W; Liebenberg, J | 1 |
| Cavalleri, D; Chappell, K; Coble, S; Drake, J; Karadzovska, D; Murphy, M; Nanchen, S; Wiseman, S | 1 |
| Curdi, JL; Gil, AE; Gomez, SA; Hernandez, JAC; Hernandez, PO; Peris, PP; Picado, A; Velasquez, RVO | 1 |
| Barbieri Bastos, IP; Botelho, CB; Campos, DR; Correia, TR; Fernandes, JI; Lopes, NL; Machado, MA; Scott, FB | 1 |
| Abbate, JM; Arfuso, F; Beugnet, F; Brianti, E; Gaglio, G; Giannetto, S; Halos, L; Napoli, E | 1 |
| Beccati, M; Beugnet, F; Bourdeau, P; Brement, T; Bruet, V; Cekiera, A; Crosaz, O; Darmon, C; Guillot, J; Halos, L; Larsen, D; Lebon, W; Mosca, M; Pin, D; Pomorska Handwerker, D; Popiel, J; Tielemans, E | 1 |
| Armstrong, R; Lavan, R; Normile, D; Tunceli, K | 1 |
| Beugnet, F; Hampel, V; Knaus, M; Rehbein, S; Schäfer, J | 1 |
| Heredia Cardenas, R; Miranda Contreras, L; Osorio Marquez, R; Rangel Díaz, J; Romero Núñez, C; Yarto Jaramillo, E | 1 |
| Aouiche, N; Beugnet, F; Lebon, W; Lekouch, N; Meyer, L; Perier, N | 1 |
| Beugnet, F; Meesaimongkon, P; Srifawattana, N; Tangtrongsup, S; Thitaram, N; Tinkruejeen, G; Tiwananthagorn, S | 1 |
| Inskeep, T; Kryda, K; Mahabir, SP; Rugg, J | 1 |
| Álvarez Zavala, MLÁ; Cruz López, E; Galicia Franco, E; Heredia Cárdenas, R; Miranda Contreras, L; Rangel Díaz, J; Romero Núñez, C; Yarto Jaramillo, E | 1 |
| Bautista Gómez, LG; Flores Ortega, A; Heredia Cárdenas, R; Martin Cordero, A; Romero Núñez, C; Sheinberg Waisburd, G; Yarto Jaramillo, E | 1 |
| Bullock, R; Carney, E; Dodds, WJ; Fritsche, HA; Jeffrey, J; Kimball, JP; Morgan, J; Palmieri, V | 1 |
| Bautista Gómez, LG; Fuantos Gámez, BA; Heredia Cardenas, R; Miranda Contreras, L; Romero Núñez, C; Sheinberg Waisburd, G; Yarto Jaramillo, E | 1 |
| Aouiche, N; Beugnet, F; Lebon, W; Liebenberg, J; Rautenbach, C; van der Mescht, L | 1 |
| Beugnet, F; Cutolo, AA; Menz, I; Perier, N; Silva, FO; Thyssen, P | 1 |
| Beugnet, F; Iatta, R; Mendoza-Roldan, JA; Otranto, D; Panarese, R; Zatelli, A | 1 |
| Akki, FE; Beugnet, F; Lebon, W; Madder, M; Meyer, L | 1 |
| Adhikari, S; Padivitage, N; Rustum, AM | 1 |
| Beugnet, F; Iatta, R; Lebon, W; Lia, RP; Otranto, D; Panarese, R | 1 |
| Drag, M; Mitchell, E; Tielemans, E | 1 |
| Dreyer, SM; Vaughan, JA | 1 |
| Beugnet, F; Deak, G; Mihalca, AD; Panait, LC; Rabei, Ș | 1 |
| Berny, P; Beugnet, F; Brianti, E; España, B; Marino, M; Mendoza-Roldan, JA; Napoli, E; Otranto, D; Perles, L; Spadola, F | 1 |
24 trial(s) available for isoxazoles and afoxolaner
| Article | Year |
|---|---|
The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs.
Topics: Acaricides; Administration, Oral; Animals; Babesia; Dermacentor; Dog Diseases; Dogs; Female; Isoxazoles; Male; Naphthalenes; Tick Infestations | 2014 |
Afoxolaner against fleas: immediate efficacy and resultant mortality after short exposure on dogs.
Topics: Animals; Ctenocephalides; Dog Diseases; Dogs; Excitatory Amino Acid Antagonists; Flea Infestations; GABA Antagonists; Insect Proteins; Insecticides; Isoxazoles; Naphthalenes; Time Factors; Treatment Outcome | 2014 |
Comparative speed of efficacy against Ctenocephalides felis of two oral treatments for dogs containing either afoxolaner or fluralaner.
Topics: Administration, Oral; Animals; Ctenocephalides; Dog Diseases; Dogs; Flea Infestations; Insecticides; Isoxazoles; Naphthalenes; Time Factors; Treatment Outcome | 2015 |
Comparative efficacy of two oral treatments for dogs containing either afoxolaner or fluralaner against Rhipicephalus sanguineus sensu lato and Dermacentor reticulatus.
Topics: Animals; Dermacentor; Dogs; Female; Insecticides; Isoxazoles; Male; Naphthalenes; Rhipicephalus sanguineus; Tick Infestations | 2015 |
Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Afoxolaner Chewable (NexGard®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial.
Topics: Administration, Oral; Administration, Topical; Animals; Dog Diseases; Dogs; Imidazoles; Insecticides; Isoxazoles; Ixodidae; Naphthalenes; Neonicotinoids; Nitro Compounds; Pyrethrins; Tick Infestations | 2015 |
Speed of flea knockdown of spinosad compared to afoxolaner, and of spinosad through 28 days post-treatment in controlled laboratory studies.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Flea Infestations; Insecticides; Isoxazoles; Macrolides; Naphthalenes; Siphonaptera; Time Factors; United States | 2015 |
Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced infestations with Dermacentor reticulatus in dogs.
Topics: Acaricides; Administration, Oral; Animals; Dermacentor; Dog Diseases; Dogs; Drug Combinations; Isoxazoles; Macrolides; Naphthalenes; Tick Infestations; Treatment Outcome | 2016 |
Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Follow-Up Studies; Imidazoles; Isoxazoles; Macrolides; Male; Mite Infestations; Naphthalenes; Neonicotinoids; Nitro Compounds; Skin; Tablets; Time Factors | 2016 |
Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix(®)) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs.
Topics: Acaricides; Administration, Oral; Administration, Topical; Animals; Arachnid Vectors; Dog Diseases; Dogs; Drug Combinations; Drug Therapy, Combination; Ehrlichia canis; Ehrlichiosis; Imidazoles; Insecticides; Isoxazoles; Naphthalenes; Neonicotinoids; Nitro Compounds; Permethrin; Rhipicephalus sanguineus; Tick Infestations | 2016 |
Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Naphthalenes; Sarcoptes scabiei; Scabies; Skin | 2016 |
Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
Topics: Administration, Oral; Analysis of Variance; Animals; Anthelmintics; Aorta, Thoracic; Autopsy; Body Weight; Dog Diseases; Dogs; Esophagoscopy; Esophagus; Feces; Female; Isoxazoles; Macrolides; Male; Naphthalenes; Parasite Egg Count; Spirurida Infections; Thelazioidea | 2016 |
Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs.
Topics: Angiostrongylus; Animals; Anthelmintics; Dog Diseases; Dogs; Drug Administration Schedule; Drug Synergism; Female; Isoxazoles; Macrolides; Male; Naphthalenes; Strongylida Infections; Tablets | 2016 |
Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Dog Diseases; Dogs; Female; Isoxazoles; Macrolides; Male; Naphthalenes | 2017 |
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard
Topics: Administration, Oral; Aedes; Analysis of Variance; Animals; Body Weight; Dog Diseases; Dogs; Ectoparasitic Infestations; Female; Insect Vectors; Insecticides; Isoxazoles; Male; Naphthalenes | 2017 |
A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Flea Infestations; Hospitals, Animal; Insecticides; Isoxazoles; Naphthalenes; Siphonaptera; Tablets; United States | 2017 |
Phlebotomine mortality effect of systemic insecticides administered to dogs.
Topics: Absorption, Physiological; Animals; Disease Vectors; Dog Diseases; Dogs; Drug Combinations; Female; Insecticides; Isoxazoles; Leishmania infantum; Leishmaniasis, Visceral; Macrolides; Male; Naphthalenes; Phlebotomus | 2018 |
Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Female; Insect Vectors; Insecticides; Isoxazoles; Macrolides; Male; Naphthalenes; Parasitic Diseases, Animal; Permethrin; Pyrazoles | 2018 |
Treatment of canine sarcoptic mange with afoxolaner (NexGard
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Germany; Isoxazoles; Macrolides; Male; Naphthalenes; Portugal; Random Allocation; Scabies; Tablets; Treatment Outcome | 2018 |
Effect of oral afoxolaner on naturally occurring infestations of peacocks by the louse Goniodes pavonis.
Topics: Administration, Oral; Animals; Bird Diseases; Galliformes; Isoxazoles; Mite Infestations; Naphthalenes; Phthiraptera; Random Allocation; Tablets | 2019 |
Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Administration Schedule; Female; Insecticides; Isoxazoles; Male; Naphthalenes; Phlebotomus; Tick Infestations | 2019 |
Comparative efficacy of afoxolaner and ivermectin in dogs naturally infested with Rhipicephalus sanguineus sensu lato: A clinical field study conducted in Thailand.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ivermectin; Male; Naphthalenes; Rhipicephalus sanguineus; Thailand; Tick Infestations | 2019 |
Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA.
Topics: Acaricides; Administration, Oral; Animals; Azetidines; Dermatitis; Dog Diseases; Dogs; Drug Combinations; Female; Flea Infestations; Hospitals, Animal; Isoxazoles; Macrolides; Male; Naphthalenes; Parasite Load; Pyrantel; Siphonaptera; Spiro Compounds; Tablets; Treatment Outcome; United States | 2020 |
Efficacy of a single administration of afoxolaner (NexGard®) or fipronil plus permethrin (Frontline® Tri-Act) against Hyalomma marginatum ticks in dogs.
Topics: Animals; Dog Diseases; Dogs; Isoxazoles; Naphthalenes; Permethrin; Pyrazoles; Ticks | 2021 |
Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions.
Topics: Animals; Canidae; Dog Diseases; Dogs; Ischnocera; Isoxazoles; Naphthalenes | 2022 |
40 other study(ies) available for isoxazoles and afoxolaner
| Article | Year |
|---|---|
Evaluation of the curative and preventive efficacy of a single oral administration of afoxolaner against cat flea Ctenocephalides felis infestations on dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Parasite Egg Count; Random Allocation; Treatment Outcome | 2014 |
Evaluation of the efficacy of afoxolaner against two European dog tick species: Dermacentor reticulatus and Ixodes ricinus.
Topics: Acaricides; Animals; Dermacentor; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Naphthalenes; Parasite Load; Random Allocation; Tick Infestations; Treatment Outcome | 2014 |
Assessment of the efficacy of orally administered afoxolaner against Rhipicephalus sanguineus sensu lato.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Naphthalenes; Random Allocation; Rhipicephalus sanguineus; Tick Infestations; Treatment Outcome | 2014 |
Evaluation of the efficacy of afoxolaner against Haemaphysalis longicornis on dogs.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodidae; Male; Naphthalenes; Random Allocation; Tick Infestations; Treatment Outcome | 2014 |
NEXGARD®. Afoxolaner, a new oral insecticide-acaricide to control fleas and ticks in dogs. Editorial.
Topics: Acaricides; Animals; Dogs; Flea Infestations; Insecticides; Isoxazoles; Naphthalenes; Siphonaptera; Tick Infestations; Ticks | 2014 |
Safety evaluation of orally administered afoxolaner in 8-week-old dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Body Weight; Dogs; Female; Isoxazoles; Male; Naphthalenes; Random Allocation; Safety | 2014 |
Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs.
Topics: Animals; Antiparasitic Agents; Chloride Channels; Cockroaches; Dog Diseases; Dogs; Drosophila melanogaster; Electrophysiological Phenomena; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Oocytes; Protein Binding; Random Allocation; Siphonaptera; Tick Infestations; Ticks; Xenopus laevis | 2014 |
Curative and preventive efficacy of orally administered afoxolaner against Ctenocephalides canis infestation in dogs.
Topics: Administration, Oral; Animals; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Parasite Egg Count; Parasite Load; Treatment Outcome | 2014 |
The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs.
Topics: Administration, Intravenous; Administration, Oral; Animals; Antiparasitic Agents; Area Under Curve; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Protein Binding; Tick Infestations | 2014 |
Efficacy of afoxolaner against Ixodes scapularis ticks in dogs.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Naphthalenes; Parasite Load; Random Allocation; Tick Infestations; Treatment Outcome | 2014 |
Assessment of the onset of action of afoxolaner against existing adult flea (Ctenocephalides felis) infestations on dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Ctenocephalides; Dog Diseases; Dogs; Female; Flea Infestations; Isoxazoles; Male; Naphthalenes; Random Allocation; Time | 2014 |
Immediate efficacy and persistent speed of kill of a novel oral formulation of afoxolaner (NexGardTM) against induced infestations with Ixodes ricinus ticks.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Ixodes; Male; Naphthalenes; Random Allocation; Tick Infestations; Time Factors | 2014 |
Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA.
Topics: Administration, Oral; Animals; Animals, Domestic; Dog Diseases; Dogs; Drug Evaluation; Female; Flea Infestations; Insecticides; Isoxazoles; Male; Naphthalenes; Pest Control; Pets; Siphonaptera | 2015 |
[New drugs for small animals in 2014].
Topics: Animals; Cats; Dogs; Guanidines; Insulin; Isoxazoles; Ketoconazole; Naphthalenes; Neonicotinoids; Nitro Compounds; Pyrimidines; Sulfonamides; Veterinary Drugs | 2015 |
Comparative speed of kill of oral treatments with Simparica™ (sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Insecticides; Isoxazoles; Ixodes; Naphthalenes; Placebos; Random Allocation; Survival Analysis; Tick Infestations; Time Factors; Treatment Outcome | 2016 |
Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA.
Topics: Animals; Dog Diseases; Dogs; Flea Infestations; Florida; Insecticides; Isoxazoles; Naphthalenes; Pruritus; Siphonaptera | 2016 |
Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced gastrointestinal nematode infections in dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Combinations; Isoxazoles; Macrolides; Naphthalenes; Nematode Infections; Random Allocation; Treatment Outcome | 2016 |
Development and Validation of a Reversed-Phase Chiral HPLC Method to Determine the Chiral Purity of Bulk Batches of (
Topics: Antiparasitic Agents; Chromatography, High Pressure Liquid; Isoxazoles; Naphthalenes; Stereoisomerism | 2017 |
Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe.
Topics: Animals; Antinematodal Agents; Dog Diseases; Dogs; Europe; Feces; Isoxazoles; Macrolides; Naphthalenes; Nematoda; Nematode Infections; Praziquantel; Tablets; Treatment Outcome | 2017 |
Development and Validation of a Normal Phase Chiral HPLC Method for Analysis of Afoxolaner Using a Chiralpak® AD-3 Column.
Topics: Amylose; Chemistry Techniques, Analytical; Chromatography, High Pressure Liquid; Isoxazoles; Naphthalenes; Phenylcarbamates; Reproducibility of Results; Stereoisomerism | 2016 |
A comparative laboratory trial evaluating the immediate efficacy of fluralaner, afoxolaner, sarolaner and imidacloprid + permethrin against adult Rhipicephalus sanguineus (sensu lato) ticks attached to dogs.
Topics: Acaricides; Administration, Oral; Animals; Dog Diseases; Dogs; Female; Imidazoles; Isoxazoles; Male; Naphthalenes; Neonicotinoids; Nitro Compounds; Parasite Load; Permethrin; Random Allocation; Rhipicephalus sanguineus; Tick Infestations; Treatment Outcome | 2016 |
Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Insecticides; Isoxazoles; Mite Infestations; Naphthalenes; Otoscopy; Psoroptidae; Treatment Outcome | 2016 |
Comparative speed of kill of sarolaner (Simparica
Topics: Animals; Australia; Azetidines; Dog Diseases; Dogs; Isoxazoles; Ixodes; Naphthalenes; Parasite Load; Placebos; Random Allocation; Spiro Compounds; Survival Analysis; Tick Infestations; Time Factors | 2017 |
Efficacy of afoxolaner plus milbemycin oxime chewable tablets (NexGard Spectra
Topics: Ancylostoma; Ancylostomiasis; Animals; Anthelmintics; Dog Diseases; Dogs; Drug Combinations; Female; Isoxazoles; Macrolides; Male; Naphthalenes; Tablets | 2017 |
Afoxolaner and fluralaner treatment do not impact on cutaneous Demodex populations of healthy dogs.
Topics: Acaricides; Animals; Dog Diseases; Dogs; Female; Isoxazoles; Male; Mite Infestations; Mites; Naphthalenes; Treatment Outcome | 2017 |
Efficacy of afoxolaner in the treatment of otodectic mange in naturally infested cats.
Topics: Acaricides; Animals; Cat Diseases; Cats; Isoxazoles; Mite Infestations; Naphthalenes; Treatment Outcome | 2018 |
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.
Topics: Acaricides; Administration, Oral; Animals; Anthelmintics; Dog Diseases; Dogs; Drug Compounding; Female; Isoxazoles; Macrolides; Male; Mite Infestations; Mites; Naphthalenes; Skin; Treatment Outcome | 2018 |
Dog owner flea/tick medication purchases in the USA.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Flea Infestations; Hospitals, Animal; Humans; Insecticides; Isoxazoles; Macrolides; Medication Adherence; Naphthalenes; Ownership; Prescription Drugs; Records; Siphonaptera; Ticks; United States; Veterinary Drugs; Veterinary Medicine | 2018 |
Use of afoxolaner for the treatment of lice (Goniodes pavonis) in different genera (Chrysolophus spp, Lophura spp, Phasianus spp, and Syrmaticus spp) and species of pheasants and West Mexican Chachalacas (Ortalis poliocephala).
Topics: Animals; Bird Diseases; Galliformes; Insect Control; Insecticides; Ischnocera; Isoxazoles; Lice Infestations; Naphthalenes | 2020 |
Evaluation of the effect of afoxalaner with milbemycin 1 oxime in the treatment of rabbits naturally infected with Psoroptes cuniculi.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Isoxazoles; Macrolides; Mite Infestations; Naphthalenes; Psoroptidae; Rabbits | 2020 |
Survey of canine use and safety of isoxazoline parasiticides.
Topics: Animals; Antiparasitic Agents; Azetidines; Dog Diseases; Dogs; Flea Infestations; Isoxazoles; Naphthalenes; Spiro Compounds; Tick Infestations | 2020 |
Successful treatment of Ophionyssus natricis with afoxolaner in two Burmese pythons (Python molurus bivittatus).
Topics: Animals; Boidae; Isoxazoles; Mite Infestations; Mites; Naphthalenes | 2020 |
Insecticidal efficacy of afoxolaner against bedbugs, Cimex lectularius, when administered orally to dogs.
Topics: Administration, Oral; Animals; Bedbugs; Dogs; Insecticides; Isoxazoles; Naphthalenes | 2021 |
Efficacy of afoxolaner (NexGard®) on the treatment of myiasis caused by the New World screwworm fly Cochliomyia hominivorax (Diptera: Calliphoridae) in naturally infested dogs.
Topics: Animals; Calliphoridae; Diptera; Dog Diseases; Dogs; Isoxazoles; Myiasis; Naphthalenes | 2021 |
Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area.
Topics: Animals; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Endemic Diseases; Female; Insect Vectors; Isoxazoles; Leishmania infantum; Leishmaniasis, Visceral; Mosquito Vectors; Naphthalenes; Psychodidae; Weather | 2021 |
Assay of afoxolaner and determination of its related substances in commercial bulk batches of afoxolaner by reversed-phase HPLC method based on a short octadecyl column.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Isoxazoles; Limit of Detection; Linear Models; Naphthalenes; Reproducibility of Results | 2021 |
Efficacy of afoxolaner for the treatment of ear mite infestation under field conditions.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Isoxazoles; Mite Infestations; Mites; Naphthalenes; Treatment Outcome | 2021 |
Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1-deficient collie dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Isoxazoles; Macrolides; Naphthalenes | 2022 |
Survival and Fecundity of Anopheles stephensi and Anopheles albimanus Mosquitoes (Diptera: Culicidae) After Ingesting Bovine Blood Containing Various Veterinary Systemic Parasiticides.
Topics: Animals; Anopheles; Antiparasitic Agents; Cattle; Cattle Diseases; Fertility; Insecticides; Isoxazoles; Ivermectin; Malaria; Mosquito Control; Mosquito Vectors; Naphthalenes | 2022 |
Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae).
Topics: Animals; Dog Diseases; Dogs; Isoxazoles; Mite Infestations; Mites; Snakes | 2023 |